| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |